Chicago, ILNCT05194566Now EnrollingIRB Ready

Post-stroke Aphasia Clinical Trial in Chicago, IL

Access cutting-edge post-stroke aphasia treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by QVITI S.A.

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access post-stroke aphasia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related post-stroke aphasia treatment provided free

Apply for This Chicago Location

Check if you qualify for this post-stroke aphasia clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Post-stroke Aphasia Study in Chicago

The aim of the trial is to determine whether 75Hz transcranial alternating current stimulation (tACS) synchronized with therapeutic linguistic tasks is an effective form of therapy for post-stroke aphasia.

Sponsor: QVITI S.A.

Who Can Participate

Inclusion Criteria

diagnosis of aphasia: Broca's or mixed (based on the assessment of a Speech Language Pathologist).
presence of a focus of injury in the left hemisphere (within one hemisphere only) as a result of the first ischemic or hemorrhagic stroke (based on CT/MRI examination);
chronic stage of the disease - time since the stroke occurred over 6 months.
ability to achieve an accuracy in the Naming Task of 10-60%.
18-80 years
right-handedness before the stroke.
ability to give informed written consent.
fluency in English.

Exclusion Criteria

severe cognitive, auditory or visual impairment that would preclude cognitive and language testing - inability to follow a two-step command.
presence of metal implants in the skull.
presence of major untreated or unstable psychiatric disease.
history of epilepsy or seizures.
ongoing medication that increases the risk of epileptic seizures.
presence in the body of cardiac stimulator, pacemaker or vagus nerve stimulator (implanted).
history of speech, language, hearing, or intellectual disability during childhood.
pregnancy (based on declarations) Exclusion criteria during the trial:
high intolerance to stimulation.
occurrence of an epileptic seizure.
other previously absent neurological or mental symptoms Withdrawal criteria:
high intolerance to stimulation (participants experience severe discomfort during stimulation);
occurrence of an epileptic seizure;
other previously absent neurological, physical or mental symptoms.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT05194566) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Post-stroke Aphasia Treatment Options in Chicago, IL

If you're searching for post-stroke aphasia treatment options in Chicago, IL, this clinical trial (NCT05194566) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced post-stroke aphasia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all post-stroke aphasia clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Chicago, IL

See all stroke clinical trials recruiting in Chicago — not just this study.

Browse Stroke Trials in Chicago →

Browse More Trials by Condition

Stroke TrialsAnkylosing Spondylitis TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL